Marla Shapiro

Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study

Samuel Lederman, Faith D Ottery, Antonio Cano et al. · The Lancet · 2023 · 244 citations

Pharmacy, Gynecology, Pharmacotherapy +11

Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health

Stephanie S. Faubion, Lisa Larkin, Cynthia A. Stuenkel et al. · Menopause The Journal of The North American Menopause Society · 2018 · 232 citations

Medicine, Endocrinology, Oncology +13

Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT

Kimball A. Johnson, Nancy Martin, Rossella E. Nappi et al. · The Journal of Clinical Endocrinology & Metabolism · 2023 · 193 citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +13

Physician response to informed consent regulations for randomized clinical trials

Kathryn M. Taylor, Marla Shapiro, Colin L. Soskolne et al. · Cancer · 1987 · 51 citations · Full text

Public Health, Health Policy, Clinical Research Regulation +13

Update on herpes zoster vaccination: a family practitioner's guide.

Marla Shapiro, Brent Kvern, Peter N.C. Watson et al. · PubMed · 2011 · 30 citations

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17